Clinical trial
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
NCT02233049 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
- Lead sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- October 31, 2014
- Completion date
- October 31, 2018
- Enrollment
- 250 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.